Christoph Diehl

Christoph Diehl

Auto-generated profile, based on publicly available information

Christoph Diehl

Department of Biochemistry and Synthetic Metabolism, Max Planck Institute for Terrestrial Microbiology, Marburg, Germany

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 December 2023 in Nature Catalysis
Verified
Journal Article
Open access
PDF file
SLShanshan Luo
Shanshan Luo
CDChristoph Diehl
Christoph Diehl
HHHai He
Hai He
YBYoungJun Bae
YoungJun Bae
MKMelanie Klose
Melanie Klose
TETobias Erb
Tobias Erb
Synthetic biology offers the opportunity to build solutions for improved capture and conversion of carbon dioxide (CO2) that outcompete those evolved by nature. Here we demonstrate the design and construction of a new-to-nature CO2-fixation pathway, the reductive tricarboxylic acid branch/4-hydroxybutyryl-CoA/ethylmalonyl-CoA/acetyl-CoA (THETA) cycle. The THETA cycle encompasses 17 enzymes from 9 organisms and revolves around two of the most efficient CO2-fixing enzymes described in nature, crotonyl-CoA carboxylase/reductase and phosphoenolpyruvate carboxylase. Here using rational and machine learning-guided optimization approaches, we improved the yield of the cycle by two orders of magnitude and demonstrated the formation of different biochemical building blocks directly from CO2. Furthermore, we separated the THETA cycle into three modules that we successfully implemented in vivo by exploiting the natural plasticity of Escherichia coli metabolism. Growth-based selection and/or 13C-labelling confirmed the activity of three different modules, demonstrating the first step towards realizing highly orthogonal and complex CO2-fixation pathways in the background of living cells.

16 June 2023 in Science Advances
Verified
Journal Article
Open access
RMRichard McLean
Richard McLean
TSThomas Schwander
Thomas Schwander
CDChristoph Diehl
Christoph Diehl
NCNiña Socorro Cortina
Niña Socorro Cortina
NPNicole Paczia
Nicole Paczia
TETobias Erb
Tobias Erb
Nature has evolved eight different pathways for the capture and conversion of CO 2 , including the Calvin-Benson-Bassham cycle of photosynthesis. Yet, these pathways underlie constrains and only represent a fraction of the thousands of theoretically possible solutions. To overcome the limitations of natural evolution, we introduce the HydrOxyPropionyl-CoA/Acrylyl-CoA (HOPAC) cycle, a new-to-nature CO 2 -fixation pathway that was designed through metabolic retrosynthesis around the reductive carboxylation of acrylyl-CoA, a highly efficient principle of CO 2 fixation. We realized the HOPAC cycle in a step-wise fashion and used rational engineering approaches and machine learning–guided workflows to further optimize its output by more than one order of magnitude. Version 4.0 of the HOPAC cycle encompasses 11 enzymes from six different organisms, converting ~3.0 mM CO 2 into glycolate within 2 hours. Our work moves the hypothetical HOPAC cycle from a theoretical design into an established in vitro system that forms the basis for different potential applications.

5 December 2022 in Nature Chemical Biology
Verified
Journal Article
Open access
PDF file
CDChristoph Diehl
Christoph Diehl
PGPatrick D. Gerlinger
Patrick D. Gerlinger
NPNicole Paczia
Nicole Paczia
TETobias Erb
Tobias Erb
Anaplerosis is an essential feature of metabolism that allows the continuous operation of natural metabolic networks, such as the citric acid cycle, by constantly replenishing drained intermediates. However, this concept has not been applied to synthetic in vitro metabolic networks, thus far. Here we used anaplerotic strategies to directly access the core sequence of the CETCH cycle, a new-to-nature in vitro CO2-fixation pathway that features several C3–C5 biosynthetic precursors. We drafted four different anaplerotic modules that use CO2 to replenish the CETCH cycle’s intermediates and validated our designs by producing 6-deoxyerythronolide B (6-DEB), the C21-macrolide backbone of erythromycin. Our best design allowed the carbon-positive synthesis of 6-DEB via 54 enzymatic reactions in vitro at yields comparable to those with isolated 6-DEB polyketide synthase (DEBS). Our work showcases how new-to-nature anaplerotic modules can be designed and tailored to enhance and expand the synthetic capabilities of complex catalytic in vitro reaction networks.

12 July 2024 in Science
Verified
Journal Article
Closed access
SGSimone Giaveri
Simone Giaveri
NBNitin Bohra
Nitin Bohra
CDChristoph Diehl
Christoph Diehl
HYHao Yuan Yang
Hao Yuan Yang
MBMartine Ballinger
Martine Ballinger
TETobias Erb
Tobias Erb
One of the hallmarks of living organisms is their capacity for self-organization and regeneration, which requires a tight integration of metabolic and genetic networks. We sought to construct a linked metabolic and genetic network in vitro that shows such lifelike behavior outside of a cellular context and generates its own building blocks from nonliving matter. We integrated the metabolism of the crotonyl-CoA/ethyl-malonyl-CoA/hydroxybutyryl-CoA cycle with cell-free protein synthesis using recombinant elements. Our network produces the amino acid glycine from CO 2 and incorporates it into target proteins following DNA-encoded instructions. By orchestrating ~50 enzymes we established a basic cell-free operating system in which genetically encoded inputs into a metabolic network are programmed to activate feedback loops allowing for self-integration and (partial) self-regeneration of the complete system.

3 May 2021 in Angewandte Chemie
Verified
Journal Article
Open access
PDF file
SSSrividhya Sundaram
Srividhya Sundaram
CDChristoph Diehl
Christoph Diehl
NCNiña Socorro Cortina
Niña Socorro Cortina
JBJan Bamberger
Jan Bamberger
NPNicole Paczia
Nicole Paczia
TETobias Erb
Tobias Erb
Eines der Ziele für die Realisierung nachhaltiger chemischer Syntheseverfahren ist die direkte Nutzung des Treibhausgases CO2 als Rohstoff für die Produktion von Grund‐ und Feinchemikalien, wie z. B. Pharmazeutika, Duftstoffe und Lebensmittelzusatzstoffe. In dieser Studie präsentieren wir eine modulare In‐vitro‐Plattform für die kontinuierliche Umwandlung von CO2 in komplexe Kohlenstoff‐Verbindungen, wie Monoterpene (C10), Sesquiterpene (C15) und Polyketide. Durch Kombination von natürlichen und synthetischen Stoffwechselwegen etablierten wir eine neue Route von CO2 zu den Schlüsselintermediaten Acetyl‐ und Malonyl‐CoA, welche anschließend durch verschiedene Terpen‐ und Polyketidsynthasen diversifiziert werden können. In unserer Machbarkeitsstudie demonstrieren wir die Kombination verschiedener Stoffwechselmodule mit bis zu 29 Enzymen in einem Ansatz. Dies ebnet den Weg für die weitere Entwicklung und Optimierung von Syntheserouten für die Erzeugung komplexer CO2‐basierter Chemikalien.

1 August 2012
Verified
Book
Open access
CDChristoph Diehl
Christoph Diehl